![]() | |
Type | Private |
---|---|
Location | , , U.S. |
Campus | Urban |
Website | mir |
The Mallinckrodt Institute of Radiology (MIR), established 1931, is an academic radiology center associated with the Washington University School of Medicine, located within the Washington University Medical Center in St. Louis, Missouri. In addition to providing diagnostic and therapeutic patient-care services, the institute is a top research and education center. It employs over 140 academic staff and is among the top recipients of National Institutes of Health funding of radiology departments. [1] [2] The center provides radiology services to Barnes-Jewish and St. Louis Children's hospitals, as well as multiple other hospitals and outpatient centers in the St. Louis area. The center performs 700,000 examinations and procedures annually. [3]
Mallinckrodt has for decades been considered the premier radiology residency training program in the United States and has consistently been ranked among the top three radiology training programs in the country. In 2020, Doximity ranked the institute at #2, [4] and U.S. News & World Report ranked the institute at #5 in radiology in the United States. [5]
At the beginning of the 20th century, the discipline of radiology was still in its infancy. Early medical imaging consisted primarily of x-ray studies used for diagnostic evaluation, and the clinical application for such tests was still being explored. Although Washington University School of Medicine began providing radiology services in 1910, there was no academic division of radiology at that time.
In the 1920s, prominent Washington University thoracic surgeon, Evart Graham, became interested in developing an imaging test to assess the gallbladder and biliary system. It was already known that chemical agents such as phenolphthalein, once ingested, were concentrated by the liver and secreted into bile in dogs. Graham enlisted the help of Edward Mallinckrodt, Sr., owner of local pharmaceutical company Mallinckrodt Chemical Works, to contribute chemists to the work of developing a chemical which could be used to help visualize the gallbladder by imaging. Once the chemical compound and techniques were refined for use clinical use in humans, the techniques were published in 1924 and cholecystography quickly became a widely accepted clinical procedure. [6]
Success with this early imaging development prompted the creation of a radiology department in 1925. In 1928, philanthropist Edward Mallinckrodt, Jr. (son of Edward Mallinckrodt, Sr., and Washington University board of trustees member) endowed Mallinckrodt Institute of Radiology in his father's name. [7] The MIR cornerstone was laid in 1930, and MIR was in operation by 1931 with a staff of four radiologists and a physicist. [8] Resident training began in 1933. [3]
In 1964, Mallinckrodt became the site for the first cyclotron specifically developed for medical studies. Radioactive materials from this cyclotron were later used to develop positron emission tomography. [9]
Positron emission tomography (PET) is a functional imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities including blood flow, regional chemical composition, and absorption. Different tracers are used for various imaging purposes, depending on the target process within the body.
Radiology is the medical specialty that uses medical imaging to diagnose diseases and guide their treatment, within the bodies of humans and other animals. It began with radiography, but today it includes all imaging modalities, including those that use no ionizing electromagnetic radiation, as well as others that do, such as computed tomography (CT), fluoroscopy, and nuclear medicine including positron emission tomography (PET). Interventional radiology is the performance of usually minimally invasive medical procedures with the guidance of imaging technologies such as those mentioned above.
Nuclear medicine, or nucleology, is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear imaging is, in a sense, radiology done inside out, because it records radiation emitted from within the body rather than radiation that is transmitted through the body from external sources like X-ray generators. In addition, nuclear medicine scans differ from radiology, as the emphasis is not on imaging anatomy, but on the function. For such reason, it is called a physiological imaging modality. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans are the two most common imaging modalities in nuclear medicine.
Scintigraphy, also known as a gamma scan, is a diagnostic test in nuclear medicine, where radioisotopes attached to drugs that travel to a specific organ or tissue (radiopharmaceuticals) are taken internally and the emitted gamma radiation is captured by gamma cameras, which are external detectors that form two-dimensional images in a process similar to the capture of x-ray images. In contrast, SPECT and positron emission tomography (PET) form 3-dimensional images and are therefore classified as separate techniques from scintigraphy, although they also use gamma cameras to detect internal radiation. Scintigraphy is unlike a diagnostic X-ray where external radiation is passed through the body to form an image.
Washington University School of Medicine in St. Louis is the medical school of Washington University in St. Louis, located in the Central West End neighborhood of St. Louis, Missouri. Founded in 1891, the School of Medicine shares a campus with Barnes-Jewish Hospital, St. Louis Children's Hospital, and the Alvin J. Siteman Cancer Center.
Molecular imaging is a field of medical imaging that focuses on imaging molecules of medical interest within living patients. This is in contrast to conventional methods for obtaining molecular information from preserved tissue samples, such as histology. Molecules of interest may be either ones produced naturally by the body, or synthetic molecules produced in a laboratory and injected into a patient by a doctor. The most common example of molecular imaging used clinically today is to inject a contrast agent into a patient's bloodstream and to use an imaging modality to track its movement in the body. Molecular imaging originated from the field of radiology from a need to better understand fundamental molecular processes inside organisms in a noninvasive manner.
Michel Matthew Ter-Pogossian was an American medical physicist. He was professor of radiology at the Washington University School of Medicine for over 30 years. A pioneer in nuclear medicine, he is best known for his research on the positron emission tomography (PET). He is considered one of its creators and often referred to as the "father of PET."
Mallinckrodt Pharmaceuticals plc is an American-Irish domiciled manufacturer of specialty pharmaceuticals, generic drugs and imaging agents. In 2017, it generated 90% of its sales from the U.S. healthcare system. While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S. Mallinckrodt's 2013 tax inversion to Ireland drew controversy when it was shown Acthar was Medicaid's most expensive drug.
Michael Edward Phelps is a professor and an American biophysicist. He is known for being one of the fathers of positron emission tomography (PET).
Evarts Ambrose Graham was an American academic, physician, and surgeon.
Nuclear medicine physicians, also called nuclear radiologists or simply nucleologists, are medical specialists that use tracers, usually radiopharmaceuticals, for diagnosis and therapy. Nuclear medicine procedures are the major clinical applications of molecular imaging and molecular therapy. In the United States, nuclear medicine physicians are certified by the American Board of Nuclear Medicine and the American Osteopathic Board of Nuclear Medicine.
David Edmund Kuhl was an American scientist specializing in nuclear medicine. He was well known for his pioneering work in positron emission tomography. Dr. Kuhl served as the Chief of the Division of Nuclear Medicine at the University of Michigan for 20 years and retired in June 2011.
Carlos Alberto Pérez was an American radiation oncologist. He is well known for his contributions to the clinical management of patients, especially those with gynecologic tumors and carcinoma of the prostate, the breast and head and neck.
Zang-Hee Cho is a Korean neuroscientist who developed the first Ring-PET scanner and the scintillation detector BGO. More recently, Cho developed the first PET-MRI fusion molecular imaging device for neuro-molecular imaging.
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is a cancer treatment, research and education institution with six locations in the St. Louis area. Siteman is the only cancer center in Missouri and within 240 miles of St. Louis to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). Siteman is also the only area member of the National Comprehensive Cancer Network, a nonprofit alliance of 32 cancer centers dedicated to improving the quality and effectiveness of cancer care.
Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these agents.
Samuel Achilefu is a Nigerian-born scientist and medical researcher who has pioneered both fundamental and applied research in science, engineering, and medicine. Dr. Samuel Achilefu is Professor and Chair of the Department of Biomedical Engineering at the University of Texas Southwestern Medical Center, where he holds the Lyda Hill Distinguished University Chair in Biomedical Engineering. He is also Professor of Radiology and a member of the Simmons Comprehensive Cancer Center. Before joining UT Southwestern, he was the Michel M. Ter-Pogossian Professor of Radiology and Vice Chair for Innovation and Entrepreneurship at the Mallinckrodt Institute of Radiology, Washington University School of Medicine. He held joint appointments as a professor of medicine, biochemistry and molecular biophysics, and biomedical engineering. He also served as the Director of the Washington University Molecular Imaging Center and the privately funded Theranostic Innovation Program and was co-director of the Center for Multiple Myeloma Nanotherapy and co-Leader of the Oncologic Imaging Program of the Alvin J. Siteman Cancer Center at Washington University.
Jason S. Lewis is a British radiochemist whose work relates to oncologic therapy and diagnosis. His research focus is a molecular imaging-based program focused on radiopharmaceutical development as well as the study of multimodality small- and biomolecule-based agents and their clinical translation. He has worked on the development of small molecules as well as radiolabeled peptides and antibodies probing the overexpression of receptors and antigens on tumors.
Christine O. "Cooky" Menias is an American radiologist, Mayo Clinic College of Medicine and Science professor, and editor designate of RadioGraphics, one of the leading educational journals in radiology.
Pamela K. Woodard is an American radiologist specializing in cardiovascular imaging. She is the Elizabeth E. Mallinckrodt Professor of Radiology and the Director the Mallinckrodt Institute of Radiology at Washington University in Saint Louis. She also holds appointments as a professor of Internal Medicine, Pediatrics, and Biomedical Engineering at the Washington University in St. Louis. She was elected a Fellow of the American Association for the Advancement of Science in 2022.